NCT00125294 2017-09-25
Sublingual Methadone for the Management of Cancer Breakthrough Pain
AHS Cancer Control Alberta
Phase 1 Completed
AHS Cancer Control Alberta
Mario Negri Institute for Pharmacological Research
Norwegian University of Science and Technology